dacarbazine
Miscellaneous compounds - Dacarbazine was approved for medical use in the United States in 1975. It is also known as imidazole carboxamide, is a chemotherapy medication used in the treatment of melanoma and Hodgkin's lymphoma.. Reference standards of Dacarbazine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
Dacarbazine - Impurity D (Freebase)
Catalogue No.:PA 04 02041
CAS :
124-40-3
Molecular Formula : C2H7N
Molecular Weight : 45.08

